uPA (PLAU) (NM_002658) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC202083L3V

  • LentiORF®

Lenti ORF particles, PLAU (Myc-DDK tagged) - Human plasminogen activator, urokinase (PLAU), transcript variant 1, 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP



Need custom lentivirus service?
Get a free quote

CNY 8,930.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (3)
Lenti ORF control particles of pLenti-C-Myc-DDK-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00


PLAU mouse monoclonal antibody, clone OTI5H4 (formerly 5H4)
    • 100 ul

CNY 1,999.00
CNY 2,700.00

Specifications

Product Data
Product Name uPA (PLAU) (NM_002658) Human Tagged ORF Clone Lentiviral Particle
Synonyms ATF; BDPLT5; QPD; u-PA; UPA; URK
Vector pLenti-C-Myc-DDK-P2A-Puro
ACCN NM_002658
ORF Size 1293 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RC202083).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_002658.2
RefSeq Size 2395 bp
RefSeq ORF 1296 bp
Locus ID 5328
Domains KR, Tryp_SPc
Protein Families Druggable Genome, ES Cell Differentiation/IPS, Protease
Protein Pathways Complement and coagulation cascades
MW 48.5 kDa
Gene Summary This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...